One IPO and six SPACs came to market this past week, and one major issuer joined the pipeline as February comes to a close.

SpaceX is targeting filing confidentially for an initial public offering as soon as next month, according to people familiar with the matter, as billionaire Elon Musk’s rocket and satellite company ...

Half a decade after the pandemic boom, a disturbing number of companies that went public via SPAC have gone bust. For ...

Among Singapore’s army boys, “no horse run” refers to the especially fleet-footed among them. The uniquely Singapore phrase, a direct translation from Hokkien bo beh zao, which came from the ...

Explore the top crypto presale for 2026? IPO Genie combines AI deal screening, a $1M raise, Redwood AI proof, plus 35% bonus ...

Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial ...

An upcoming IPO is not a guaranteed profit opportunity. It is simply a new stock sale where you must decide whether the business is good and whether t ...

While big name money is backing Firmus, not everyone in the market is convinced by the story, with its co-founder’s colourful past and sustainability claims among the concerns.

Securities and Exchange Commission Chairman Paul Atkins testified that U.S. public companies spend approximately $2.7 billion a year preparing annual reports. Atkins proposed a 3-pillar plan for his ...

Fractal Analytics launched its Rs 2,834 crore IPO on Monday, February 9, at a time when India’s IT industry is experiencing significant turbulence. Shares of major IT services companies, including TCS ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...